The Future of Steroids – Doctor’s Prediction

Member Access Required

Already a member? Sign In

Timeline

00:00

The speaker opens by explaining his experience working with thousands of men using performance drugs. He describes stimulants and amphetamines as common tools for cognitive and wakefulness performance.

01:56

He shifts to endurance related drugs that raise oxygen carrying capacity for demanding sports. He then argues classic anabolic steroids will persist because they are accessible and affordable.

03:58

He predicts underground labs and personalized designer steroids will expand with global internet access. He also discusses future hopes for safer SARMs and stronger testosterone boosting compounds.

05:55

He describes human growth hormone, IGF-1, and secretagogues as costly but increasingly discussed agents. He lists insulin, thyroid preparations, clenbuterol, and diuretics as drugs people already misuse today.

07:58

He introduces gene doping and viral vector gene therapy as inevitable future performance technologies. He cites spinal muscular atrophy treatment costs and warns of serious health consequences.

09:58

He returns to ethics, urging more studies and less politicization of testosterone replacement therapy. He warns that expensive gene technologies could widen divides in physiques, health, and longevity.

Video Summary

The speaker bases his prediction on caring for thousands of men over fifteen years. He says steroid use and other performance enhancement drugs reach far beyond bodybuilding. He lists bodybuilders, power lifters, strongmen, athletes, actors, military, and police users. He defines a PED as any drug that improves performance from cognition to physical output. At the head level, he expects stimulants and amphetamines to remain common performance drugs. He describes cognitive and wakefulness medications as tools that keep the brain more stimulated. He then points to cardiovascular performance drugs that increase oxygen carrying capacity for endurance.

He says classic anabolic androgenic steroids will be business as usual for future users. He argues these drugs stay effective, affordable, and accessible to millions worldwide. He mentions testosterone derivatives and oral drugs like Dianabol as familiar examples. He predicts internet access will keep underground labs and global supply from disappearing. He expects more people to alter compounds and create personalized designer steroids to reduce side effects. He says selective androgen receptor modulators may someday become effective and safe for medical use. He also expects more testosterone boosters, pro hormones, and growth hormone related products to circulate.

He warns that common medicines will also be used, including insulin, thyroid preparations, and clenbuterol. He adds diuretics and dangerous drugs like DNP to the list of future misuse. He predicts researchers will keep altering these agents into new synthetic iterations. He says gene doping through viral vector gene therapy will eventually be used for performance. He cites a 2019 FDA approved gene therapy for spinal muscular atrophy that can cost over two million dollars. He mentions muscle wasting disorders like Duchenne muscular dystrophy as major research targets. He closes by calling for more studies, education, and less discrimination toward people using these drugs.

Drug Callouts

Amphetamines

Amphetamines are stimulant medications that increase central nervous system activity and alertness. The speaker says stimulants and amphetamines are already used to enhance brain performance.

Testosterone

Testosterone is the primary androgen hormone and a common medical replacement therapy drug. He mentions testosterone derivatives as classic steroid options that will continue in future markets.

Dianabol

Dianabol is an oral anabolic steroid, also called methandrostenolone, used to increase muscle mass. He lists Dianabol among familiar oral drugs that remain accessible through internet supply.

Insulin

Insulin is a hormone medication used to control blood glucose in people with diabetes. He names insulin as a common medicine that some people misuse for performance enhancement.

Clenbuterol

Clenbuterol is a beta agonist drug that can stimulate airways and increase heart strain. The transcript includes clenbuterol in a list of cheap drugs used and abused today.

Human growth hormone

Human growth hormone is a peptide hormone used medically for specific growth disorders. He says growth hormone products and related boosters will circulate more as science becomes accessible.

IGF-1

IGF-1 is insulin like growth factor one, a hormone linked to growth signaling in tissues. He notes IGF-1 is very expensive and expects it to become more relevant over time.

DNP

DNP is a toxic chemical that disrupts cellular energy production and can cause dangerous overheating. He calls DNP a dangerous drug that is already in use and will continue.

Condition Callouts

Spinal muscular atrophy

Spinal muscular atrophy is a genetic motor neuron disease causing severe muscle weakness in infants. He references an FDA approved viral vector gene therapy for spinal muscular atrophy in 2019.

Duchenne muscular dystrophy

Duchenne muscular dystrophy is an inherited disorder causing progressive muscle degeneration and weakness. The speaker cites Duchenne muscular dystrophy as an example of muscle wasting research driving gene advances.

Muscle wasting disorders

Muscle wasting disorders are diseases where muscle mass and strength decline over time. He says research in muscle wasting disorders will enable therapies later misused for performance.

Key Takeaways

Performance enhancement drugs are defined broadly, from brain stimulants to endurance agents.
Classic anabolic steroids remain affordable and accessible, so he expects continued global use.
He predicts underground labs will produce personalized designer steroids to mitigate side effects.
He lists insulin, thyroid preparations, clenbuterol, diuretics, and DNP as misused medicines.
Gene therapy successes for spinal muscular atrophy foreshadow ethical dilemmas and cost divides.